Abstract
Staphylococcus aureus is responsible for the majority of wound infections in clean surgical procedures that involve implantation of foreign material, grafts or prosthetic devices. The aim of the study was to assess the effect of low molecular weight heparin on the development and progression of S. aureus arthritis. The murine model of hematogenously acquired septic arthritis was used injecting intravenously toxic shock syndrome toxin-1 (TSST-1) producing S. aureus of LS-1 strain. Mice lacking prosthetic implants were treated with intraperitoneal injections of low molecular weight heparin, used routinely as anti-thrombotic prophylaxis following joint prosthetic surgery. Evaluation of arthritis was performed clinically and histopathologically. In addition, the effect of low molecular weight heparin on T cell dependent and independent inflammation was assessed. Seven days after inoculation with bacteria 18 out of 19 low molecular weight heparin treated mice displayed clinical symptoms of arthritis as compared to 9 out of 23 control animals (p < 0.05), and the severity of arthritis, expressed as arthritic index, was 2.6+/-0.5 versus 1.6+/-0.5 (p = 0.05). The histopathological examination confirmed the clinical findings showing that...Continue Reading
References
May 1, 1978·Medicine·D L Goldenberg, A S Cohen
Jan 1, 1992·Journal of Biomaterials Science. Polymer Edition·P VaudauxJ Jozefonvicz
Jul 1, 1992·European Journal of Biochemistry·S BozziniP Speziale
Jan 1, 1992·Advances in Experimental Medicine and Biology·H P EkreI Cohen
Aug 1, 1991·Infection and Immunity·T BremellA Tarkowski
Nov 1, 1990·Arthritis and Rheumatism·T BremellA Tarkowski
Mar 1, 1990·European Journal of Immunology·O LiderY Naparstek
Jan 1, 1989·Scandinavian Journal of Rheumatology·T H ChristensenH Westh
May 24, 1984·The New England Journal of Medicine·J N Sheagren
Nov 1, 1983·Cellular Immunology·M S SyB Benacerraf
Apr 1, 1994·Scandinavian Journal of Immunology·A AbdelnourA Tarkowski
May 1, 1994·European Journal of Immunology·A AbdelnourA Tarkowski
Apr 29, 1994·Biochemical Pharmacology·B LomonteL A Hanson
Jun 1, 1994·Infection and Immunity·T BremellA Tarkowski
Sep 1, 1993·Infection and Immunity·A AbdelnourA Tarkowski
Dec 1, 1995·Arthritis and Rheumatism·C J KaandorpM A van de Laar
Jul 1, 1997·Infection and Immunity·M Verdrengh, A Tarkowski
Dec 31, 1997·Clinical and Experimental Immunology·E SakinieneA Tarkowski
Jan 1, 1997·Drugs·E MiniP Periti
May 29, 1998·Acta Orthopaedica Scandinavica·G SchippingerK Babinski
Sep 18, 1998·Drugs & Aging·E C van GorpJ W ten Cate
Oct 30, 1998·Inflammation·M HeinzelmannF N Miller
Feb 5, 1999·Clinical and Experimental Immunology·E SakinieneA Tarkowski
Oct 16, 1999·Archives of Surgery·C A WeissG J Beilman